gyki 53655 has been researched along with cyclic gmp in 1 studies
| Studies (gyki 53655) | Trials (gyki 53655) | Recent Studies (post-2010) (gyki 53655) | Studies (cyclic gmp) | Trials (cyclic gmp) | Recent Studies (post-2010) (cyclic gmp) |
|---|---|---|---|---|---|
| 111 | 0 | 22 | 22,346 | 333 | 4,062 |
| Protein | Taxonomy | gyki 53655 (IC50) | cyclic gmp (IC50) |
|---|---|---|---|
| Phosphodiesterase | Bos taurus (cattle) | 0.1 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase B | Homo sapiens (human) | 2.4 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 2.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Falcone, JF; Manro, JR; Merchant, KM; Ryder, JW; Svensson, KA | 1 |
1 other study(ies) available for gyki 53655 and cyclic gmp
| Article | Year |
|---|---|
Pharmacological characterization of cGMP regulation by the biarylpropylsulfonamide class of positive, allosteric modulators of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Topics: Allosteric Regulation; Amides; Animals; Benzodiazepines; Biphenyl Compounds; Cerebellum; Cyclic GMP; Dizocilpine Maleate; Male; Mice; Receptors, AMPA; Sulfonamides; Synaptic Transmission | 2006 |